Proteomics Market Summary
Allied Market Research published a report, titled, “Proteomics Market by Component (Reagents, Instruments, and Services), and Application (Drug Discovery, Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “proteomics market” was valued at $32.8 billion in 2023, and is estimated to reach $161.9 billion by 2035, growing at a CAGR of 14.2% from 2024 to 2035.
Key Takeaways
- On the basis of component, the reagent segment dominated the market in terms of revenue in 2023.
- On the basis of application, the drug discovery segment dominated the market in terms of revenue in 2023.
- On the basis of region, North America dominated the market in terms of revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Access the Sample Report: https://www.alliedmarketresearch.com/request-sample/1677
How Technological Innovations are Transforming the Proteomics Industry
Proteomics is the study of comprehensive analysis of proteins present in biological systems. It is widely used in protein identification, structural proteomics, post-translational modifications (PTMs), protein qualification, and more. The industry is expanding owing to rise in technology and technique advancements, increase in use of personalized medications, and significant R&D expenditures by major players and research institutions. Major companies such as Thermo Fisher Scientific Inc., Agilent Technologies, Bruker Corporations, and many others have adopted strategic alliances, joint ventures, and acquisitions to promote technological innovation and strengthen their position in the industry.
Various tools and techniques utilized in proteomics
The study of proteins is an important aspect of biology, as they are the actual functional molecules in cells. Thus, proteomics is also an emerging sector, and relies on various techniques and tools, including mass spectrometry (MS), 2D gel electrophoresis, bioinformatics, and liquid chromatography (LC) to study proteins at length.
2D gel electrophoresis enables researchers to see protein patterns by separating proteins according to their molecular weight and isoelectric point. In addition, mass spectrometry is typically used in combination with liquid chromatography to identify and quantify proteins, as well as to measure the mass-to-charge ratio of peptides. Bioinformatics contributes to analyze and interpret proteomic data, further helping understand protein interactions and pathways with the use of specialized software. Also, innovation in these techniques enable proteomics to be more advanced in terms of sensitivity, scalability, and accessibility, in key applications such as biomarker discovery, personalization of medicines, and drug development. For example, single cell proteomics improvements are the most recent advancements in mass spectrometry, which allow for accurate and high-throughput measurement of proteins from individual cells. Additional developments include integration of AI and ML algorithms for de novo sequencing, function prediction, and automated data interpretation.
Ongoing developments in applications revolutionizing the sector
As per the Proteomics Market, it finds diverse applications in varied fields, which focuses on personalization and precision medicines, wherein protein profiles allow for tailored treatments and help identify disease biomarkers. According to AMR, the industry is estimated to rise at a CAGR of 14.2% from 2024 to 2035. Moreover, as precision medicine witnesses rise in demand, proteomics is likely to play a key role in identifying disease-specific biomarkers, allowing for early diagnosis and targeted therapies. Integration of AI and ML is one of the important factors, which is anticipated to improve data interpretation, promote advances in drug discovery, and improve clinical outcomes. Proteomics tracks tumor-specific proteins and signaling pathways, also has the ability to early detection, prognosis, and therapy monitoring in the field of cancer research. Also, they are widely used in toxicology and drug discovery to find new drug targets and assess how medications impact protein expressions. Furthermore, owing to the COVID-19 pandemic, the industry has seen rise in applications that support the study of infectious diseases and the development of vaccines by focusing on and clarifying host-pathogen interactions and immune responses. Various trends highlight a shift toward more targeted approaches of proteomics in other end uses, including neuroproteomics, spatial proteomics, agriculture, and environmental proteomics.
Acquire Latest Proteomics Market Research Report for Industry Insights: https://www.alliedmarketresearch.com/connect-to-analyst/1677
Innovations in mass spectrometry by Thermo Fisher redefining proteomics
Thermo Fisher Scientific, in recent times, has introduced various product advancements in proteomics to enable high sensitivity, throughput, and automation. Its most famous advancement, Orbitrap Eclipse Tribrid mass spectrometry, has undergone several upgradation processes, to enhance faster acquisition speeds, and improve single-cell proteomics capabilities. In latest news, Thermo Fisher Scientific Inc. at the 2025 American Society for Mass Spectrometry (ASMS) conference, announced the launch of the Thermo Scientific Orbitrap Astral Zoom mass spectrometry and Thermo Scientific Orbitrap Excedion Pro mass spectrometry. Both these instruments are developed and designed in a way to advance scientific discovery by improving and upgrading capabilities in proteomics, clinical research, and drug discovery. In addition, Thermo Fisher is actively adopting strategies such as product launches and acquisitions, which demonstrate its capabilities to strengthen its presence in the market, along with fostering innovation in the field. Thermo Fisher’s strategy to launch innovative tools highlights its dedication to offering state-of-the-art instruments utilized in a broad range of applications, including fundamental research, and clinical and pharmaceutical developments. These instruments improve workflows and enable scientific breakthroughs across a range of fields by incorporating cutting-edge technologies.
View Sample Data & Findings: https://www.alliedmarketresearch.com/purchase-enquiry/1677
Leading Market Players
- Bio-Rad Laboratories Inc
- Thermo Fisher Scientific Inc
- Danaher Corporation
- Bruker Corporation
- Waters Corporation
- Perkin Elmer Inc
- Horiba Ltd.
- Merck KGaA
- Agilent Technologies Inc
- Li-Cor Inc
In conclusion
The proteomics industry is expected to witness highly promising growth in the years to come, owing to rapid increase in technological advancements, high demand for personalized medicine, and rise in applications in healthcare, agriculture, and environmental sciences. In addition, the number of point-of-care diagnostics is on the rise, especially in emerging markets, which is anticipated to offer lucrative opportunities for portable and cost-effective proteomics solutions.
Furthermore, owing to increased R&D investments and strategic partnerships between biotech, pharmaceutical, and research institutes and academies, the industry is also anticipated to experience growth and innovation during the forecast period.
Other Trending Reports in Life Science Domain-
How Big Is the Healthcare Predictive Analytics Market by 2033? Size, Share & CAGR Analysis
Immune Checkpoint Inhibitors Market From USD 40.1 Billion in 2022 to USD 189.4 Billion by 2032
USD 12.3+ Bn Nerve Repair and Regeneration Market Value Cross by 2030 | Allied Market Research
How Big Is the Rabies Vaccine Market by 2032? Size, Share & CAGR Analysis
Advanced Wound Care Market Size & Share | $17.8 Billion by 2032, Growing at 5.6% CAGR
